Home » Education and Training » Scripps Genomics Primer » Genomics 101: A Primer
Key word / concept | Slide set | Slide # |
---|---|---|
1000 Genomes Project | Pharmacogenomics | 17 |
Allele | Genotyping | 2 |
Cancer | ||
- Gene pathways | Cancer Genomics | 28 |
---- APC/Hedgehog | Cancer Genomics | 30 |
---- Apoptosis | Cancer Genomics | 30 |
---- Glioma-associated | Cancer Genomics | 31 |
---- Hypoxia-inducible factor-1 | Cancer Genomics | 29 |
---- PI3K | Cancer Genomics | 32 |
---- Receptor tyrosine kinase | Cancer Genomics | 29 |
---- Retinoblastoma | Cancer Genomics | 31 |
---- SMAD | Cancer Genomics | 32 |
- Identifying cancer genes | Cancer Genomics | 15-18 |
- Mutations | Cancer Genomics | |
---- Cancer Gene Census | Cancer Genomics | 21-22 |
---- Categories | Cancer Genomics | 23 |
---- Gene types | ||
-------- Proto oncogenes | Cancer Genomics | 12 |
-------- Tumor suppressor genes | Cancer Genomics | 13 |
-------- Stability/caretaker genes | Cancer Genomics | 14 |
---- Inherited | ||
-------- oncogenes | Cancer Genomics | 37 |
-------- tumor suppressor genes | Cancer Genomics | 34-36 |
---- Somatic (by pathway) | Cancer Genomics | 38-41 |
- Properties of cancer cells | Cancer Genomics | 6-9 |
- Types | Cancer Genomics | 5 |
---- Breast | Cancer Genomics | 24 |
---- Colorectal | Cancer Genomics | 25 |
---- Prostate | 26 | |
- Validating cancer genes | 19 | |
Cancer Genome Atlas | Pharmacogenomics | 18 |
Cancer Genomics | 20 | |
Cells | ||
- general | Basics | 2 |
- somatic cell | DNA and Heredity | 9 |
- germline cell | DNA and Heredity | 9 |
- stem cell | DNA and Heredity | 9 |
Chromosomes | ||
- general | DNA and Heredity | 2 |
- abnormalities. | ||
---- cause | Mutations | 8-9 |
---- numerical | Mutations | 4-5 |
---- risk factors | Mutations | 10 |
---- structural | Mutations | 4-6 |
DNA | ||
- composition | Basics | 3 |
- markers | Genotyping | 2 |
- types, | ||
---- autosomal | DNA and Heredity | 4 |
---- X chromosome | DNA and Heredity | 5 |
---- Y chromosome | DNA and Heredity | 6 |
---- Mitochondrial | DNA and Heredity | 7 |
Genes | ||
- coding | Basics | 4 |
- non-coding | Basics | 4 |
Gene testing | ||
- available tests | Gene Testing | 6 |
- definition | Gene Testing | 2 |
- disease prediction | Gene Testing | 7-8 |
- ethical concerns | Genetics in Society | |
- genetic risk | Gene Testing | 9 |
- issues | Gene Testing | 5 |
- pros & cons | Gene Testing | 4 |
- reasons for | Gene Testing | 3 |
Genetic Legislation | ||
- Genetic Information Nondiscrimination Act (GINA) | Genetics in Society | 3-4 |
- Genomics and Personalized Medicine Act | ||
- Laboratory Test Improvement Act | Genetics in Society | 5 |
- Newborn Screening Saves Lives Act | ||
Genetics in Society | 6 | |
Genetics in Society | 7 | |
Genotype | ||
- definition | Genotyping | 4 |
- assays, | ||
---- PCR | Genotyping | 11 |
---- DNA fragment analysis | Genotyping | 11 |
---- Allele-specific probes | Genotyping | 12 |
---- DNA sequencing | Genotyping | 12 |
---- DNA microarrays/beads | Genotyping | 13 |
GWAS | ||
- benefit to public | GWAS | 5 |
- definition | GWAS | 3 |
- interpretation | GWAS | 9 |
- methodology | GWAS | 7-8 |
- purpose | GWAS | 4 |
- use in disease | GWAS | 6 |
Haplotype | Genotyping | 6-8 |
International HapMap Project | GWAS | 2 |
Meiosis | Mutations | 8 |
Mitosis | Mutations | 8 |
Mutation | ||
- chromosomal abnormalities | Mutations | 4-6 |
- types, | ||
---- deletion | Mutations | 7 |
---- duplication | Mutations | 7 |
---- inversion | Mutations | 7 |
---- translocation | Mutations | 7 |
---- rings | Mutations | 7 |
Omics | ||
- cascade | ‘Omics’ | 3 |
- comprehensive ‘omics’ | ‘Omics’ | 5 |
- definitions | ‘Omics’ | 4 |
Pharmacogenetics Knowledge Base | Pharmacogenomics | 18 |
Pharmacogenomics | ||
- application in drug development | Pharmacogenomics | 8 |
- ethical concerns | Genetics in Society | 9-10 |
- evolution | Pharmacogenomics | 2-7 |
- examples, | ||
---- CYP2C19 | Pharmacogenomics | 14-15 |
---- CACNA1C | Pharmacogenomics | 16 |
Pharmacodynamics | Pharmacogenomics | 10-11 |
Pharmacokinetics | Pharmacogenomics | 10-11 |
Proteins | ||
- structure | Basics | 5 |
Sequencing | ||
- exome, targeted | Sequencing | 10-13 |
- next-generation methods, | ||
---- in vitro amplification | Sequencing | 7 |
---- parallelized screening | Sequencing | 7 |
---- ligation | Sequencing | 8 |
---- microfluidic Sanger | Sequencing | 8 |
- next next-gen methods, | ||
---- hybridization | Sequencing | 9 |
---- mass spectrometry | Sequencing | 9 |
---- other, under development | Sequencing | 9 |
- timeline | Sequencing | 3-5 |
Single nucleotide polymorphisms | ||
- categories, | ||
---- causative | Mutations | 14 |
---- linked | Mutations | 14 |
- definition | Mutations | 12 |
- in GWAS | GWAS | 8 |
- properties | Mutations | 13 |
- use | Genotyping | 6-9 |